You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
26 August 2026 - Japanese healthcare company Daiichi Sankyo Co Ltd (TYO:4568) announced on Wednesday that the first patient has been dosed in the phase 3 TROPION-Urothelial04 trial evaluating Datroway (datopotamab deruxtecan) as an adjuvant treatment...
26 August 2026 - Japanese stainless steel products manufacturer Nippon Kinzoku Co Ltd (TOKYO:5491) announced on Wednesday that it has begun mass production of ultra-thin, narrow-width stainless steel optimised for laser welding in ultra-fine insulin ...
26 August 2026 - Biotechnology company 4basebio PLC (AIM: 4BB) announced on Wednesday that it has signed a non-exclusive Strategic Collaboration and Marketing Agreement with gene therapy CDMO Genezen to provide drug developers with access to its rese...
26 August 2026 - Inify Laboratories AB (Euronext Growth Oslo:INIFY), a laboratory service that provides diagnostics within pathology, announced on Wednesday that it has launched operations in the UK after completing its laboratory and receiving regul...
26 August 2026 - Taiwan-based biopharmaceutical company Senhwa Biosciences Inc (TPEx:6492) announced on Tuesday that it has completed enrolment in a Phase 1b expansion trial evaluating pidnarulex (CX-5461) monotherapy in patients with advanced solid ...
26 August 2026 - Cellenkos Inc, a clinical-stage biotechnology company developing tissue-directed, cord blood-derived T-regulatory (Treg) cell therapies, announced on Tuesday that the US Food and Drug Administration (FDA) has granted Fast Track desig...
26 August 2026 - German pharmaceutical company Revier Therapeutics announced on Tuesday the closing of a EUR6m seed financing and the launch of its operations.The company says that it has established the first therapeutic approach to selectively targ...